RxDoctor Payments Data

Kaye Sedarsky, MD

Clinical Neurophysiology · Walla Walla, WANPI 1790047868

Payments from drug & device makers

$298in general payments, 2019–2025

Across 13 payments — averaging $22.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$54
  • Pfizer$47
  • TG Therapeutics, Inc.$39
  • Zimmer Biomet$39
  • Cala Health, Inc.$39
  • Amgen$26
  • plus $54 from 3 others

What the payments were for

  • Food & beverage$298100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few clinical neurophysiology providers in Washingtonto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$56,130
Medicare patients
154
Services billed
1,298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Carbidopa-LevodopaCarbidopa/Levodopa15$516
Memantine Hcl11$272
Donepezil Hcl19$156

Paid to pharmacies, not to this prescriber.

Other clinical neurophysiology in Walla Walla

Where these figures come from

Is this you, or does something look wrong? →